News: Atrial Fibrillation

Atrial fibrillation is a rhythm disorder of the heart characterized by extra heartbeats in the upper chambers of the heart.

Metabolomics is the study of the unique chemical fingerprint left by cells.

Your Apple watch is now a medical device.

With a $5 million grant from the Patient-Centered Outcomes Research Institute (PCORI) and the American Heart Association, University of Utah Health is leading a center to develop and test tools...

A new study revealed patients receiving radiofrequency catheter ablation compared to traditional drug therapies for atrial fibrillation (AF), a contributing factor to heart failure, had significantly lower hospitalization and mortality...

Radiofrequency catheter ablation lowered hospitalization and mortality rates by 47 and 44 percent respectively in patients with atrial fibrillation (AF), a contributing factor to heart failure.

The CARMA Center at the University of Utah Health Care kicked off a clinical trial aiming to improve the treatment of atrial fibrillation.

Why you should continue taking it despite a report questioning its safety.

In patients with atrial fibrillation, delayed enhancement magnetic resonance imaging (DE-MRI) performed before ablative treatment can help predict whether treatment will be successful or not, according to results of a...

When finished in December 2014, the Ray and Tye Noorda Oral Health Education Building will house the University's newly founded School of Dentistry.

Noted scholar and researcher begins at University of Utah on Sept. 1